Employer record no. 20081
Colossal Biosciences, Inc.
US DOL LCA disclosure data, FY2022 to FY2026
Total LCA filings
18
Certified
14
Denied
0
FY2025 filings
1
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#2,495 of 4,681 other employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2022 | 6 | 6 | 0 | $158,333 | $95,569 |
| FY2023 | 1 | 1 | 0 | $130,000 | $77,771 |
| FY2024 | 7 | 4 | 0 | $122,857 | $81,480 |
| FY2025 | 1 | 1 | 0 | $125,000 | $91,312 |
| FY2026 * | 3 | 2 | 0 | $122,042 | $90,189 |
What they file for
- scientist, genome engineering$125,0004
- embryologist$145,0003
- stem cell biology scientist$130,0003
- director of engineering innovation$200,0002
- marsupial assisted reproduction lead$130,0002
- associate, genome engineering$80,0001
- lead marsupial reproductive scientist$130,0001
- scientist ii$136,0801
Where
- dallas, tx14
- cambridge, ma3
- ste. 103, tx1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Colossal Biosciences, Inc. and any other employer they watch.
Certification rate 77.8%How these numbers are computed